5月28日，微创医疗盘中下跌5.12%，报7.42港元/股，成交额7826.82万港元。
消息面上，摩根士丹利近日发布研报，将微创医疗目标价由16港元大幅下调至10.5港元，控股公司折价从30%提高至45%，主要原因为流动性放缓及行业情绪低迷。该行指出，管理层指引上半年仅录得低单位数增长，且受中东冲突影响，介入及骨科产品海外交付出现中断。此外，医疗保健设备板块整体走弱，微创机器人-B跌4.14%、爱康医疗跌4.29%、先健科技跌3.87%，行业性抛压加剧个股跌幅。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.